Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB) — Stella
Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB)
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(1 site)
France
Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR, Créteil, Val De Marne